Test Bank Pharmacology A Patient-CenteredNursing Process Approach,
11th Edition by Linda E. McCuistion
Contents
Chapter 01: The Nursing Process and Patient-Centered Care ...........................................................................................................................2
Chapter 02: Drug Development and Ethical Considerations ............................................................................................................................6
Chapter 03: Pharmacokinetics and Pharmacodynamics................................................................................................................................... 12
Chapter 04: Pharmacogenetics ............................................................................................................................................................................. 23
Chapter 05: Complementary and Alternative Therapies .................................................................................................................................. 25
Chapter 06: Pediatric Considerations .................................................................................................................................................................. 29
Chapter 07: Geriatric Considerations .................................................................................................................................................................. 34
Chapter 08: Drugs in Substance Use Disorder.................................................................................................................................................. 38
Chapter 09: Safety and Quality ............................................................................................................................................................................ 43
Chapter 10: Drug Administration ........................................................................................................................................................................ 47
Chapter 11: Drug Calculations ............................................................................................................................................................................. 51
Chapter 12: Fluid Volume and Electrolytes ....................................................................................................................................................... 55
Chapter 13: Vitamin and Mineral Replacement ................................................................................................................................................ 62
Chapter 14: Nutritional Support .......................................................................................................................................................................... 67
Chapter 15: Adrenergic Agonists and Antagonists ........................................................................................................................................... 73
Chapter 16: Cholinergic Agonists and Antagonists .......................................................................................................................................... 77
Chapter 17: Stimulants .......................................................................................................................................................................................... 82
Chapter 18: Depressants ....................................................................................................................................................................................... 85
Chapter 19: Antiseizure Drugs ............................................................................................................................................................................. 90
Chapter 20: Drugs for Parkinsonism and Alzheimer Disease......................................................................................................................... 96
Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms ...................................................................................................... 100
Chapter 22: Antipsychotics and Anxiolytics .................................................................................................................................................... 105
Chapter 23: Antidepressants and Mood Stabilizers ........................................................................................................................................ 110
Chapter 24: Antiinflammatories ......................................................................................................................................................................... 116
Chapter 25: Analgesics ........................................................................................................................................................................................ 121
Chapter 26: Penicillins, Other Beta-Lactams, and Cephalosporins .............................................................................................................. 126
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, andLipopeptides ................................................. 130
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones .............................................................................. 132
Chapter 29: Sulfonamides and Nitroimidazoles Antibiotics ......................................................................................................................... 135
Chapter 30: Antituberculars, Antifungals, and Antivirals .............................................................................................................................. 139
Chapter 31: Antimalarials, Anthelmintics, and Peptides ................................................................................................................................ 145
Chapter 32: HIV- and AIDS-Related Drugs ................................................................................................................................................... 148
Chapter 33: Transplant Drugs............................................................................................................................................................................ 151
Chapter 34: Vaccines ........................................................................................................................................................................................... 153
Chapter 35: Anticancer Drugs ........................................................................................................................................................................... 156
Chapter 36: Targeted Therapies to Treat Cancer............................................................................................................................................ 160
Chapter 37: Biologic Response Modifiers ........................................................................................................................................................ 163
Chapter 38: Upper Respiratory Disorders........................................................................................................................................................ 167
Chapter 39: Lower Respiratory Disorders ....................................................................................................................................................... 172
Chapter 40: Cardiac Glycosides, Antianginals, and Antidysrhythmics......................................................................................................... 177
1|Page
,Chapter 41: Diuretics........................................................................................................................................................................................... 185
Chapter 42: Antihypertensives ............................................................................................................................................................................ 189
Chapter 43: Anticoagulants, Antiplatelets, and Thrombolytics..................................................................................................................... 195
Chapter 44: Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow .................................................................................... 202
Chapter 45: Gastrointestinal Tract Disorders.................................................................................................................................................. 207
Chapter 46: Antiulcer Drugs .............................................................................................................................................................................. 214
Chapter 47: Eye and Ear Disorders .................................................................................................................................................................. 220
Chapter 48: Dermatologic Disorders ................................................................................................................................................................ 224
Chapter 49: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders ........................................................................................................... 229
Chapter 50: Antidiabetics.................................................................................................................................................................................... 236
Chapter 51: Urinary Disorders ........................................................................................................................................................................... 243
Chapter 52: Pregnancy and Preterm Labor...................................................................................................................................................... 248
Chapter 53: Labor, Delivery, and Postpartum................................................................................................................................................. 255
Chapter 54: Neonatal and Newborn ................................................................................................................................................................. 260
Chapter 55: Women’s Reproductive Health .................................................................................................................................................... 262
Chapter 56: Men’s Health and Reproductive Disorders ................................................................................................................................ 268
Chapter 57: Sexually Transmitted Infections ................................................................................................................................................... 273
Chapter 58: Adult and Pediatric Emergency Drugs ....................................................................................................................................... 276
Chapter 01: The Nursing Process and Patient-Centered Care
MULTIPLE CHOICE
1. All of the following would be considered subjective data, EXCEPT:
a. Patient-reported health history
b. Patient-reported signs and symptoms of their illness
c. Financial barriers reported by the patient’s caregiver
d. Vital signs obtained from the medical record
ANS: D
Subjective data is based on what patients or family members communicate to the nurse. Patient-reported
health history, signs and symptoms, and caregiver reported financial barriers would beconsidered subjective
data. Vital signs obtained from the medical record would be considered objective data.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning
MSC: NCLEX: Management of Client Care
2. The nurse is using data collected to define a set of interventions to achieve the most desirableoutcomes.
Which of the following steps is the nurse applying?
a. Recognizing cues (assessment)
b. Analyze cues & prioritize hypothesis (analysis)
c. Generate solutions (planning)
d. Take action (nursing interventions)
ANS: C
When generating solutions (planning), the nurse identifies expected outcomes and uses the patient’s
problem(s) to define a set of interventions to achieve the most desirable outcomes. Recognizing cues
(assessment) involves the gathering of cues (information) from the patient about their health and lifestyle
practices, which are important facts that aid the nurse in making clinical care decisions. Prioritizing
hypothesis is used to organize and rank the patient problem(s)identified. Finally, taking action involves
implementation of nursing interventions to accomplishthe expected outcomes.
2|Page
, DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Client Care
3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for episodes of
hyperglycemia. The parents tell the nurse that they can’t keep track of everything that has to be done to care
for their child. The nurse reviews medications, diet, and symptom management withthe parents and draws up
a daily checklist for the family to use. These activities are completed inwhich step of the nursing process?
a. Recognizing cues (assessment)
b. Analyze cues & prioritize hypothesis (analysis)
c. Generate solutions (planning)
d. Take action (nursing interventions)
ANS: D
Taking action through nursing interventions is where the nurse provides patient health teaching,drug
administration, patient care, and other interventions necessary to assist the patient in accomplishing
expected outcomes.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Client Care
4. The nurse is preparing to administer a medication and reviews the patient’s chart for drug allergies,
serum creatinine, and blood urea nitrogen (BUN) levels. The nurse’s actions arereflective of which of
the following?
a. Recognizing cues (assessment)
b. Analyze cues & prioritize hypothesis (analysis)
c. Take action (nursing interventions)
d. Generate solutions (planning)
ANS: A
Recognizing cues (assessment) involves gathering subjective and objective information about thepatient and
the medication. Laboratory values from the patient’s chart would be considered collection of objective data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment MSC: NCLEX: Management of Client Care
5. Which of the following would be correctly categorized as objective data?
a. A list of herbal supplements regularly used provided by the patient.
b. Lab values associated with the drugs the patient is taking.
c. The ages and relationship of all household members to the patient.
d. Usual dietary patterns and food intake.
ANS: B
Objective data are measured and detected by another person and would include lab values. Theother
examples are subjective data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment MSC: NCLEX: Management of Client Care
6. The nurse reviews a patient’s database and learns that the patient lives alone, is forgetful, and does not have
an established routine. The patient will be sent home with three new medicationsto be taken at different
times of the day. The nurse develops a daily medication chart and enlistsa family member to put the
patient’s pills in a pill organizer. This is an example of which element of the nursing process?
a. Recognizing cues (assessment)
b. Analyze cues & prioritize hypothesis (analysis)
c. Take action (nursing interventions)
d. Generate solutions (planning)
3|Page
, ANS: C
Taking action (nursing interventions) involves education and patient care in order to assist thepatient to
accomplish the goals of treatment.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Client Care
7. A patient who is hospitalized for chronic obstructive pulmonary disease (COPD) wants to go home. The
nurse and the patient discuss the patient’s situation and decide that the patient may gohome when able to
perform self-care without dyspnea and hypoxia. This is an example of whichphase of the nursing process?
a. Recognizing cues (assessment)
b. Analyze cues & prioritize hypothesis (analysis)
c. Take action (nursing interventions)
d. Generate solutions (planning)
ANS: D
Generating solutions (planning) involves defining a set of interventions to achieve the most desirable
outcomes, which, for this patient, means being able to perform self-care activities without dyspnea and
hypoxia.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning
MSC: NCLEX: Management of Client Care
8. A patient will be sent home with a metered-dose inhaler, and the nurse is providing teaching.Which is a
correctly written expected outcome for this process?
a. The nurse will demonstrate the correct use of a metered-dose inhaler to the patient.
b. The nurse will teach the patient how to administer medication with a metered-doseinhaler.
c. The patient will know how to self-administer the medication using the metered-dose
inhaler.
d. The patient will independently administer the medication using the metered-doseinhaler at
the end of the session.
ANS: D
Expected outcomes must be patient-centered and clearly state the outcome with a reasonable deadline
and should identify components for evaluation.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process: Planning
MSC: NCLEX: Management of Client Care
9. The nurse is generating solutions (planning) for a patient who has chronic lung disease and hypoxia. The
patient has been admitted for increased oxygen needs above a baseline of 2 L/min.The nurse generates an
expected outcomes stating, “The patient will have oxygen saturations of
>95% on room air at the time of discharge from the hospital.” What is wrong with this goal?
a. It cannot be evaluated.
b. It is not measurable.
c. It is not patient-centered.
d. It is not realistic.
ANS: D
The expected outcome is not realistic because the patient is not usually on room air and shouldnot be
expected to attain that expected outcome by discharge from this hospitalization.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process: Planning
MSC: NCLEX: Management of Client Care
10. The nurse is developing a teaching plan for an elderly patient who will begin taking an
antihypertensive drug that causes dizziness and orthostatic hypotension. Which hypothesis(problem)
documented by the nurse is appropriate for this patient?
a. Deficient knowledge related to drug side effects.
4|Page
